A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a study where AZD3241 or placebo is given to patients with Parkinson's disease in a
blinded and randomized assignment. The main objective is to see if safety and tolerability of
the drug is acceptable.